Immediate Impact
47 standout
Citing Papers
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Works of Patrick Bedford being referenced
Considering Cell Therapy Product “Good Manufacturing Practice” Status
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Patrick Bedford | 44 | 21 | 19 | 28 | 6 | 91 | |
| Laura Bryant | 142 | 36 | 18 | 12 | 7 | 178 | |
| Enkhtsetseg Munkhbaatar | 25 | 29 | 5 | 14 | 6 | 77 | |
| K. Knox | 48 | 15 | 16 | 6 | 5 | 107 | |
| Jacqueline Barry | 57 | 98 | 58 | 23 | 8 | 205 | |
| Zongmin Jiang | 34 | 14 | 9 | 27 | 8 | 95 | |
| Vineela Gangalapudi | 45 | 26 | 9 | 7 | 8 | 116 | |
| Alex Yemelyanov | 115 | 16 | 11 | 15 | 9 | 199 | |
| Patty Sachamitr | 81 | 49 | 19 | 29 | 7 | 165 | |
| Erin Bresnahan | 38 | 32 | 11 | 21 | 10 | 177 | |
| Diana Bouhassira | 30 | 83 | 5 | 24 | 7 | 124 |
All Works
Loading papers...